HRH1 and atherosclerosis: In the expert-curated drug-target database used in this study, the histamine H1-receptor is the only target listed for all three drugs; however, the contradictory results from Rosenberg et al. and Raveendran et al. suggests that drug-specific off-target effects are mediating atherosclerosis treatment outcomes.